Use of an algorithm based on routine blood laboratory tests to exclude COVID-19 in a screening-setting of healthcare

Math P G Leers1, Ruben Deneer2,3, Guy J M Mostard4

  • 1Department of Clinical Chemistry & Hematology, Zuyderland Medical Center, Heerlen-Sittard, The Netherlands.

Plos One
|June 28, 2022
PubMed

Insights

The CoLab-algorithm can safely screen healthcare workers (HCWs) for COVID-19, ruling out the infection in over a third of cases. This rapid screening allows HCWs to return to work faster and reduces the need for costly RT-PCR tests.

Area of Science:

  • Clinical diagnostics
  • Infectious disease epidemiology
  • Healthcare management

Background:

  • The COVID-19 pandemic has strained hospital resources and led to significant sick leave among healthcare workers (HCWs).
  • Accurate and rapid diagnosis of SARS-CoV-2 infection is crucial for HCWs to safely return to work.
  • Current diagnostic methods, like RT-PCR, can be time-consuming and resource-intensive.

Purpose of the Study:

  • To evaluate the efficacy of the CoLab-algorithm as a screening tool for excluding COVID-19 in HCWs.
  • To determine if the CoLab-algorithm can expedite the return-to-work process for HCWs with COVID-19-related symptoms.

Main Methods:

  • A prospective study included 726 HCWs with COVID-19-related complaints from January to March 2021.
  • SARS-CoV-2 RT-PCR was performed alongside blood sample collection for the CoLab-algorithm's 10 laboratory parameters.
  • Data were analyzed using ROC curve analysis to determine the algorithm's diagnostic performance.

Main Results:

  • The CoLab-algorithm achieved an Area Under the Curve (AUC) of 0.853.
  • At a cut-off value of -6.525, the algorithm demonstrated 100% sensitivity and 34% specificity for excluding COVID-19.
  • No SARS-CoV-2 RT-PCR positive cases were missed, and COVID-19 was safely ruled out in 34% of HCWs.

Conclusions:

  • The CoLab-score is a reliable and rapid algorithm for screening HCWs for COVID-19.
  • Results are available within 1 hour, facilitating a faster return to work for negative HCWs.
  • This screening approach reduces the number of RT-PCR tests required, saving costs and resources.
Abstract